Reviews, Commentaries and Hypothesis Articles - FREE TO ALL

Full text files of all Review Articles, Commentaries and Hypothesis Articles published in Society for Endocrinology journals (Endocrine-Related Cancer, Journal of Molecular Endocrinology and Journal of Endocrinology) are freely available to all.

Details are listed below.

FREE ARCHIVE 2012

• REVIEW: Francesmary Modugno, Robin Laskey, Ashlee L Smith, Courtney L Andersen, Paul Haluska, and Steffi Oesterreich
• Hormone response in ovarian cancer: time to reconsider as a clinical target?
• Endocrine-Related Cancer19 R255–R279 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Masaki Shiota, Akira Yokomizo, and Seiji Naito
• Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
• Endocrine-Related Cancer19 R243–R253 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: David P Rose and Linda Vona-Davis
• The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression
• Endocrine-Related Cancer19 R225–R241 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: R van der Pas, W W de Herder, L J Hofland, and R A Feelders
• New developments in the medical treatment of Cushing's syndrome
• Endocrine-Related Cancer19 R205–R223 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: David A Barron andDavid R Rowley
• The reactive stroma microenvironment and prostate cancer progression
• Endocrine-Related Cancer19 R187–R204 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: Paraskevi Xekouki and Constantine A Stratakis
• Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?
• Endocrine-Related Cancer19 C33–C40 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• PROFILE: Ashley Grossman
• The road less travelled…
• Endocrine-Related Cancer19 P13–P16 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Ahter D Sanlioglu, Bahri Karacay, Mustafa Kemal Balci, Thomas S Griffith, and Salih Sanlioglu
• Therapeutic potential of VIP vs PACAP in diabetes
• Journal of Molecular Endocrinology 49 R157–R167 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Jaume Folch, Ignacio Pedrós, Iván Patraca, Francesc Sureda, Fèlix Junyent, Carlos Beas-Zarate, Ester Verdaguer, Mercè Pallàs, Carme Auladell, and Antoni Camins
• Neuroprotective and anti-ageing role of leptin
• Journal of Molecular Endocrinology 49 R149–R156 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Lacey M Litchfield and Carolyn M Klinge
• Multiple roles of COUP-TFII in cancer initiation and progression
• Journal of Molecular Endocrinology 49 R135–R148 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Silvia Giatti, Mariaserena Boraso, Roberto Cosimo Melcangi, and Barbara Viviani
• Neuroactive steroids, their metabolites, and neuroinflammation
• Journal of Molecular Endocrinology 49 R125–R134 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Alessandro Pocai
• Unraveling oxyntomodulin, GLP1's enigmatic brother
• Journal of Endocrinology 215 335–346 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: F X Donadeu, S N Schauer, and S D Sontakke
• Involvement of miRNAs in ovarian follicular and luteal development
• Journal of Endocrinology 215 323–334 (December 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Veerle M Darras and Stijn L J Van Herck
• Iodothyronine deiodinase structure and function: from ascidians to humans
• Journal of Endocrinology 215 189–206 (November 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Aurea Orozco, Carlos Valverde-R, Aurora Olvera, and Carlota García-G
• Iodothyronine deiodinases: a functional and evolutionary perspective
• Journal of Endocrinology 215 207–219 (November 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Kelly Coffey and Craig N Robson
• Regulation of the androgen receptor by post-translational modifications
• Journal of Endocrinology 215 221–237 (November 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW:Débora Cristina de Moraes, Mario Vaisman, Flavia Lucia Conceição, and Tânia Maria Ortiga-Carvalho
• Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors
• Journal of Endocrinology 215 239–245 (November 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• EDITORIAL: Wouter W de Herder and Charis Eng
• Obesity, diabetes mellitus, and cancer
• Endocrine-Related Cancer 19 E5–E7 (October 2012)
• • Extract
  • Full Text
  • Full Text (PDF)
• FOCUS REVIEW: Manami Inoue and Shoichiro Tsugane
• Insulin resistance and cancer: epidemiological evidence
• Endocrine-Related Cancer 19 F1–F8 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• FOCUS REVIEW: YunFeng Cui and Dana K Andersen
• Diabetes and pancreatic cancer
• Endocrine-Related Cancer 19 F9–F26 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• FOCUS REVIEW: Dara Hope Cohen and Derek LeRoith
• Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
• Endocrine-Related Cancer 19 F27–F45 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• FOCUS REVIEW: Mathis Grossmann and Gary Wittert
• Androgens, diabetes and prostate cancer
• Endocrine-Related Cancer 19 F47–F62 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• FOCUS REVIEW: Aimee J Varewijck and Joseph A M J L Janssen
• Insulin and its analogues and their affinities for the IGF1 receptor
• Endocrine-Related Cancer 19 F63–F75 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• FOCUS REVIEW: Roman Vangoitsenhoven, Chantal Mathieu and Bart Van der Schueren
• GLP1 and cancer: friend or foe?
• Endocrine-Related Cancer 19 F77–F88 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Gioia Altobelli
• Bioinformatics applied to gene transcription regulation
• Journal of Molecular Endocrinology 49 R51–R59 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Abby F Fleisch, Robert O Wright, and Andrea A Baccarelli
• Environmental epigenetics: a role in endocrine disease?
• Journal of Molecular Endocrinology 49 R61–R67 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Ozgur Mete, Shereen Ezzat, and Sylvia L Asa
• Biomarkers of aggressive pituitary adenomas
• Journal of Molecular Endocrinology 49 R69–R78 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Andrew Whittle
• Searching for ways to switch on brown fat: are we getting warmer?
• Journal of Molecular Endocrinology 49 R79–R87 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Clara V Alvarez, Montserrat Garcia-Lavandeira, Maria E R Garcia-Rendueles, Esther Diaz-Rodriguez, Angela R Garcia-Rendueles, Sihara Perez-Romero, Tania Vila Vila, Joana S Rodrigues, Pamela V Lear, and Susana B Bravo
• Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells
• Journal of Molecular Endocrinology 49 R89–R111 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Aurimas Vinckevicius and Debabrata Chakravarti
• Chromatin immunoprecipitation: advancing analysis of nuclear hormone signaling
• Journal of Molecular Endocrinology 49 R113–R123 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• EDITORIAL: Henri Wallaschofski
• What will metabolomics studies mean to endocrinology?
• Journal of Endocrinology 215 1–2 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Robin Haring
• Perspectives for metabolomics in testosterone replacement therapy
• Journal of Endocrinology 215 3–16 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Georg Homuth, Alexander Teumer, Uwe Völker, and Matthias Nauck
• A description of large-scale metabolomics studies: increasing value by combining metabolomics with genome-wide SNP genotyping and transcriptional profiling
• Journal of Endocrinology 215 17–28 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Nele Friedrich
• Metabolomics in diabetes research
• Journal of Endocrinology 215 29–42 (October 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Katherine A Staines, Vicky E MacRae, and Colin Farquharson
• The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling
• Journal of Endocrinology 214 241–255 (September 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Neil Sharma, Ashley Martin, and Christopher J McCabe
• Mining the proteome: the application of tandem mass spectrometry to endocrine cancer research
• Endocrine-Related Cancer 19 R149–R161 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Valdemar Maximo, Jorge Lima, Hugo Prazeres, Paula Soares and Manuel Sobrinho-Simoes
• The biology and the genetics of Hurthle cell tumors of the thyroid
• Endocrine-Related Cancer 19 R131–R147 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: M Tenhagen, P J van Diest, I A Ivanova, E van der Wall and P van der Groep
• Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets
• Endocrine-Related Cancer 19 R115–R129 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Luke A Selth, Wayne D Tilley and Lisa M Butler
• Circulating microRNAs: macro-utility as markers of prostate cancer?
• Endocrine-Related Cancer 19 R99–R113 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: Theodora S Ross
• Grace Rock's consent
• Endocrine-Related Cancer 19 C29–C31 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• PROFILE: Anne White
• Do we all feel we succeed despite the system?
• Endocrine-Related Cancer 19 P9–P12 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Gabriele Capurso, Stefano Festa, Roberto Valente, Matteo Piciucchi, Francesco Panzuto, Robert T Jensen, and Gianfranco Delle Fave
• Molecular pathology and genetics of pancreatic endocrine tumours
• Journal of Molecular Endocrinology 49 R37–R50 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Amy Warner and Jens Mittag
• Thyroid hormone and the central control of homeostasis
• Journal of Molecular Endocrinology 49 R29–R35 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Richard D Emes and William E Farrell
• Make way for the 'next generation': application and prospects for genome-wide, epigenome-specific technologies in endocrine research
• Journal of Molecular Endocrinology 49 R19–R27 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Laura Marroquí, Alejandro Gonzalez, Patricia Ñeco, Ernesto Caballero-Garrido, Elaine Vieira, Cristina Ripoll, Angel Nadal, and Ivan Quesada
• Role of leptin in the pancreatic β-cell: effects and signaling pathways
• Journal of Molecular Endocrinology 49 R9–R17 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Carmelo Quarta, Roberta Mazza, Renato Pasquali, and Uberto Pagotto
• Role of sex hormones in modulation of brown adipose tissue activity
• Journal of Molecular Endocrinology 49 R1–R7 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Juilee Rege and William E Rainey
• The steroid metabolome of adrenarche
• Journal of Endocrinology 214 133–143 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: A J Conley, R M Bernstein, and A D Nguyen
• Adrenarche in nonhuman primates: the evidence for it and the need to redefine it
• Journal of Endocrinology 214 121–131 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Peter J Hornsby
• Adrenarche: a cell biological perspective
• Journal of Endocrinology 214 113–119 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• EDITORIAL: Ian M Bird
• In the zone: understanding zona reticularis function and its transformation by adrenarche
• Journal of Endocrinology 214 109–111 (August 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: P Newsholme, E Rebelato, F Abdulkader, M Krause, A Carpinelli, and R Curi
• Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids
• Journal of Endocrinology 214 11–20 (July 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Masashi Akaike, and Toshio Matsumoto
• Effects of androgens on cardiovascular remodeling
• Journal of Endocrinology 214 1–10 (July 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Leonardo Oliveira Reis
• Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question
• Endocrine-Related Cancer 19 R93–R98 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Anna Karpathakis, Martyn Caplin and Christina Thirlwell
• Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?
• Endocrine-Related Cancer 19 R73–R92 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Fabio Pereira, Maria Jesus Larriba and Alberto Munoz
• Vitamin D and colon cancer
• Endocrine-Related Cancer 19 R51–R71 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Claudia Lanari, Victoria Wargon, Paola Rojas and Alfredo A Molinolo
• Antiprogestins in breast cancer treatment: are we ready?
• Endocrine-Related Cancer 19 R35–R50 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• PROFILE: Elaine A Ostrander
• Missteps and mistakes, friends and heroes
• Endocrine-Related Cancer 19 P5–P8 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• EDITORIAL: Anne M Deschamps and Charis Eng
• Engaging basic scientists in translational research
• Endocrine-Related Cancer 19 E1–E3 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Jonathan J Nicholls, Mary Jane Brassill, Graham R Williams, and J H Duncan Bassett
• The skeletal consequences of thyrotoxicosis
• Journal of Endocrinology 213 209–221 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• EDITORIAL: Adrian J L Clark and Anna Spada
• A new era for the Journal of Endocrinology and Journal of Molecular Endocrinology
• Journal of Endocrinology 213 207–208 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Yunli Zhou, Xun Zhang, and Anne Klibanski
• MEG3 noncoding RNA: a tumor suppressor
• Journal of Molecular Endocrinology 48 R45–R53 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Ryan J O Dowling, Saroj Niraula, Vuk Stambolic, and Pamela J Goodwin
• Metformin in cancer: translational challenges
• Journal of Molecular Endocrinology 48 R31–R43 (June 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: G Burnstock andI Novak
• Purinergic signalling in the pancreas in health and disease
• Journal of Endocrinology 213 123–141 (May 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Isabelle Leclerc, Guy A Rutter, Gargi Meur, and Nafeesa Noordeen
• Roles of Ca²⁺ ions in the control of ChREBP nuclear translocation
• Journal of Endocrinology 213 115–122 (May 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Gerard Karsenty
• The mutual dependence between bone and gonads
• Journal of Endocrinology 213 107–114 (May 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Francesco Torino, Agnese Barnabei, Liana De Vecchis, Marialuisa Appetecchia, Lidia Strigari and Salvatore M Corsello
• Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer
• Endocrine-Related Cancer 19 R21–R33 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: William D Foulkes
• Epigenetic modification and cancer: mark or stamp?
• Endocrine-Related Cancer 19 C23–C27 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: Maria E Cabanillas and Steven I Sherman
• Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma
• Endocrine-Related Cancer 19 C19–C22 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Alessandra Fierabracci
• Identifying thyroid stem/progenitor cells: advances and limitations
• Journal of Endocrinology 213 1–13 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Peter J Fuller, Yizou Yao, Jun Yang, and Morag J Young
• Mechanisms of ligand specificity of the mineralocorticoid receptor
• Journal of Endocrinology 213 15–24 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Félix Vargas, Isabel Rodríguez-Gómez, Pablo Vargas-Tendero, Eugenio Jimenez, and Mercedes Montiel
• The renin–angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations
• Journal of Endocrinology 213 25–36 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: R L Moore, Y Dai, and D V Faller
• Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer
• Journal of Endocrinology 213 37–48 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Jerzy-Roch Nofer
• Estrogens and atherosclerosis: insights from animal models and cell systems
• Journal of Molecular Endocrinology 48 R13–R29 (April 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Abraham B Roos and Magnus Nord
• The emerging role of C/EBPs in glucocorticoid signaling: lessons from the lung
• Journal of Endocrinology 212 291–305 (March 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: J Jeyabalan, M Shah, B Viollet, and C Chenu
• AMP-activated protein kinase pathway and bone metabolism
• Journal of Endocrinology 212 277–290 (March 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Barbara J Clark
• The mammalian START domain protein family in lipid transport in health and disease
• Journal of Endocrinology 212 257–275 (March 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Kai Wang and Jing Zheng
• Signaling regulation of fetoplacental angiogenesis
• Journal of Endocrinology 212 243–255 (March 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: Isabel Göhring and Hindrik Mulder
• Glutamate dehydrogenase, insulin secretion, and type 2 diabetes: a new means to protect the pancreatic β-cell?
• Journal of Endocrinology 212 239–242 (March 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Gavin P Vinson, Stewart Barker and John R Puddefoot
• The renin–angiotensin system in the breast and breast cancer
• Endocrine-Related Cancer 19 R1–R19 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: David A Potter, Douglas Yee, Zhijun Guo and Mariangellys Rodriguez
• Should diabetic women with breast cancer have their own intervention studies?
• Endocrine-Related Cancer 19 C13–C17 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: Mingzhao Xing
• Oxidative stress: a new risk factor for thyroid cancer
• Endocrine-Related Cancer 19 C7–C11 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• COMMENTARY: Robert C Fowkes and George Vlotides
• Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas
• Endocrine-Related Cancer 19 C1–C5 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• PROFILE: Marc Lippman
• Chaos theory and a career in medicine
• Endocrine-Related Cancer 19 P1–P3 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Zsolt Csaba, Stéphane Peineau, and Pascal Dournaud
• Molecular mechanisms of somatostatin receptor trafficking
• Journal of Molecular Endocrinology 48 R1–R12 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Mark Nixon, Rita Upreti, and Ruth Andrew
• 5α Reduced glucocorticoids: a story of natural selection
• Journal of Endocrinology 212 111–127 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Atul Purohit and Paul A Foster
• Steroid sulfatase inhibitors for estrogen-and androgen-dependent cancers
• Journal of Endocrinology 212 99–110 (February 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• REVIEW: Taija Saloniemi, Heli Jokela, Leena Strauss, Pirjo Pakarinen, and Matti Poutanen
• The diversity of sex steroid action: novel functions of hydroxysteroid (17β) dehydrogenases as revealed by genetically modified mouse models
• Journal of Endocrinology 212 27–40 (January 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Eric W-F Lam, Kunal Shah, and Jan J Brosens
• The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer
• Journal of Endocrinology 212 13–25 (January 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)
• THEMATIC REVIEW: Malin Hedengran Faulds, Chunyan Zhao, Karin Dahlman-Wright, and Jan-Åke Gustafsson
• The diversity of sex steroid action: regulation of metabolism by estrogen signaling
• Journal of Endocrinology 212 3–12 (January 2012)
• • Abstract
  • Full Text
  • Full Text (PDF)